Monitoring blood levels of DNA fragments shed by dying tumor cells may accurately predict skin cancer recurrence, a new study ...

A noninvasive clinicopathologic and gene expression profiling (CP-GEP)–based tool, the Merlin assay, shows promise for ...

Skin cancer, including melanoma, is highly treatable when caught in its early stages, Mitchell explained ... such as the scalp, soles of the feet and under the nails. “The examination ...

Several patient-specific factors are associated with an increased rate of advanced melanoma at presentation, including age, gender, and race.

Researchers used digital polymerase chain reaction assays to measure BRAF V600E or BRAF V600K circulating tumor DNA in ...

Study findings suggested that assessing ctDNA levels was as good or better at predicting recurrence than experimental tests ...

Monitoring blood levels of DNA fragments shed by dying tumor cells may accurately predict skin cancer recurrence, a new study shows. Monitoring blood levels of DNA fragments shed by dying tumor ...